Suppr超能文献

大鼠非酒精性脂肪性肝炎进展过程中肠黏膜屏障功能的变化

Change of intestinal mucosa barrier function in the progress of non-alcoholic steatohepatitis in rats.

作者信息

Li Sheng, Wu Wan-Chun, He Chi-Yi, Han Zhen, Jin Dao-You, Wang Lin

机构信息

Department of Gastroenterology, Yijishan Hospital, Wuhu 241001, Anhui Province, China.

出版信息

World J Gastroenterol. 2008 May 28;14(20):3254-8. doi: 10.3748/wjg.14.3254.

Abstract

AIM

To explore the change of intestinal mucosa barrier function in the progress of non-alcoholic steatohepatitis (NASH) in rats.

METHODS

Thirty-two Sprague-Dawley (SD) rats were randomly divided into control group and model group. Rats in the control group were given normal diet, and rats in the model group were given fat-rich diet. Eight rats in each group were killed at end of the 8th and 12th wk, respectively. The levels of endotoxin, D-xylose, TG, TC, ALT and AST, intestinal tissue SOD and MDA as well as intestinal mucus secretory IgA (sIgA) were measured. The pathology of liver was observed by HE staining.

RESULTS

At end of the 8th wk, there was no marked difference in the levels of endotoxin, D-xylose and sIgA between the two groups. At end of the 12th wk, rats in the model group developed steatohepatitis and had a higher serum level of endotoxin (P = 0.01) and D-xylose (P = 0.00) and a lower serum level of sIgA (P = 0.007).

CONCLUSION

Intestinal mucosa barrier malfunction may exist in NASH rats and may be an important promoter of NASH in rats.

摘要

目的

探讨大鼠非酒精性脂肪性肝炎(NASH)进程中肠黏膜屏障功能的变化。

方法

将32只Sprague-Dawley(SD)大鼠随机分为对照组和模型组。对照组大鼠给予正常饮食,模型组大鼠给予高脂饮食。每组分别于第8周和第12周结束时处死8只大鼠。检测内毒素、D-木糖、甘油三酯(TG)、总胆固醇(TC)、谷丙转氨酶(ALT)和谷草转氨酶(AST)水平、肠组织超氧化物歧化酶(SOD)和丙二醛(MDA)以及肠黏液分泌型免疫球蛋白A(sIgA)。通过苏木精-伊红(HE)染色观察肝脏病理。

结果

第8周结束时,两组内毒素、D-木糖和sIgA水平无明显差异。第12周结束时,模型组大鼠发生脂肪性肝炎,血清内毒素水平较高(P = 0.01),D-木糖水平较高(P = 0.00),血清sIgA水平较低(P = 0.007)。

结论

NASH大鼠可能存在肠黏膜屏障功能障碍,这可能是大鼠NASH的重要促进因素。

相似文献

1
Change of intestinal mucosa barrier function in the progress of non-alcoholic steatohepatitis in rats.
World J Gastroenterol. 2008 May 28;14(20):3254-8. doi: 10.3748/wjg.14.3254.
2
[Changes in the intestinal microenvironment during development of alcoholic fatty liver disease and related effects of probiotic therapy].
Zhonghua Gan Zang Bing Za Zhi. 2012 Nov;20(11):848-52. doi: 10.3760/cma.j.issn.1007-3418.2012.11.010.
3
Effects of traditional chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis.
Inflammation. 2008 Apr;31(2):121-32. doi: 10.1007/s10753-008-9057-3. Epub 2008 Feb 27.
5
Protective effects of tiopronin against high fat diet-induced non-alcoholic steatohepatitis in rats.
Acta Pharmacol Sin. 2012 Jun;33(6):791-7. doi: 10.1038/aps.2012.19. Epub 2012 Apr 30.
7
[Effect of Nrf2 and related factors on the progression of nonalcoholic steatohepatitis].
Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2014 Sep;30(5):465-70.
8
Dynamic expression of hepatic thioredoxin mRNA in rats with non-alcoholic fatty liver disease.
J Dig Dis. 2010 Apr;11(2):94-100. doi: 10.1111/j.1751-2980.2010.00422.x.
10
[Protective effect of Saccharomyces boulardii against intestinal mucosal barrier injury in rats with nonalcoholic fatty liver disease].
Zhonghua Gan Zang Bing Za Zhi. 2016 Dec 20;24(12):921-926. doi: 10.3760/cma.j.issn.1007-3418.2016.12.009.

引用本文的文献

1
Metabolic Syndrome: A Narrative Review from the Oxidative Stress to the Management of Related Diseases.
Antioxidants (Basel). 2023 Dec 8;12(12):2091. doi: 10.3390/antiox12122091.
2
The immune response as a therapeutic target in non-alcoholic fatty liver disease.
Front Immunol. 2022 Oct 10;13:954869. doi: 10.3389/fimmu.2022.954869. eCollection 2022.
6
Gut microbiota, fatty liver disease, and hepatocellular carcinoma.
Liver Res. 2018 Mar;2(1):43-51. doi: 10.1016/j.livres.2017.11.005. Epub 2018 Feb 21.
8
Immunoglobulin A and liver diseases.
J Gastroenterol. 2018 Jun;53(6):691-700. doi: 10.1007/s00535-017-1400-8. Epub 2017 Oct 26.
10
Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota.
Am J Physiol Gastrointest Liver Physiol. 2016 Dec 1;311(6):G1018-G1036. doi: 10.1152/ajpgi.00245.2016. Epub 2016 Sep 29.

本文引用的文献

1
Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis.
J Hepatol. 2007 Oct;47(4):571-9. doi: 10.1016/j.jhep.2007.04.019. Epub 2007 Jun 8.
2
Pathogenesis of steatohepatitis: insights from the study of animal models.
Acta Gastroenterol Belg. 2007 Jan-Mar;70(1):25-31.
3
Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis.
Clin Biochem. 2007 Jul;40(11):776-80. doi: 10.1016/j.clinbiochem.2007.02.006. Epub 2007 Mar 16.
4
Mitochondrial abnormality and oxidative stress in nonalcoholic steatohepatitis.
Alcohol Clin Exp Res. 2007 Jan;31(1 Suppl):S61-6. doi: 10.1111/j.1530-0277.2006.00288.x.
5
Mucosal barrier and immune mediators.
Curr Opin Gastroenterol. 2001 Nov;17(6):573-7. doi: 10.1097/00001574-200111000-00016.
6
Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis.
Am J Physiol Gastrointest Liver Physiol. 2007 Feb;292(2):G518-25. doi: 10.1152/ajpgi.00024.2006. Epub 2006 Oct 5.
9
Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency.
J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):174-82. doi: 10.1111/j.1440-1746.2005.04220.x.
10
[Guidelines for diagnosis and treatment of nonalcoholic fatty liver diseases].
Zhonghua Gan Zang Bing Za Zhi. 2006 Mar;14(3):161-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验